Drugs / Biphozyl
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial · 1 met primary | ||||||
| Phase 2 | NCT04071171 | Aug 2020 → Nov 2023 | acute kidney injury | Medical University Innsbruck | Completed | Met primary |
| Phase 41 trial | ||||||
| Phase 4 | NCT04215965 | May 2020 → Aug 2021 | — | Assistance Publique Hopitaux De Marseille | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biphozyl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04215965 ↗ |